Christine Cassiano | Chief Communications Officer |
David Chang | President, Chief Executive Officer |
Eric Schmidt | Chief Financial Officer |
Salveen Richter | Goldman Sachs |
Biren Amin | Jefferies |
Cory Kasimov | JPMorgan |
Phil Nadeau | Cowen & Company |
Mark Breidenbach | Oppenheimer |
Good morning ladies and gentlemen. Thank you for standing by, and welcome to the Allogene Therapeutics Fourth Quarter 2018 Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Please be aware that today’s conference call is being recorded. I would now like to turn the conference over to Christine Cassiano, Chief Communications Officer.